CytoCore's Dr. Gorodeski Has Second P2X7 Biomarker Paper Accepted For Publication

... CytoCore, Inc. (OTC BulletinBoard: MCDG.OB) announced that Dr. George Gorodeski, the head of CytoCore's Medical Advisory Board and Chief Scientist has had his most recent paper on the P2X7 biomarker, "The P2X7 Receptor: A Novel Biomarker of Uterine Epithelial Cancers", accepted for publication by the American Association for Cancer Research Journal: Cancer Epidemiology, Biomarkers & Prevention. [click link for full article] ...